Page 154 - Haematologica Vol. 107 - September 2022

ARTICLE - FL3B and simultaneous DLBCL
K. Koch et al.
cohort of 505 patients with long follow-up times. Br J
Haematol. 2012;156(2):225-233.
9. Koch K, Hoster E, Ziepert M, et al. Clinical, pathological and
genetic features of follicular lymphoma grade 3A: a joint analysis of the German Low-Grade and High-Grade Lymphoma Study Groups GLSG and DSHNHL. Ann Oncol. 2016;27(7):1323-1329.
10. Paul U, Richter J, Stuhlmann-Laiesz C, et al. Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC. Leuk Lymphoma. 2018;59(5):1213-1221.
11. Horn H, Schmelter C, Leich E, et al. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica. 2011;96(9):1327-1334.
12. Piccaluga PP, Califano A, Klein U, et al. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica. 2008;93(7):1033-1038.
13. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003;101(3):1149-1154.
14. Horn H, Kohler C, Witzig R, et al. Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. Haematologica. 2018;103(7):1182-1190.
15. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-282.
16. Au-Yeung KHR, Padilla LA, Burkhardt B, Woessmann W, Klapper W. Features of pediatric B-lymphoblastic lymphoma with KMT2A rearrangements in the German NHL-BFM group. The 108th Annual Meeting of the Japanese Society of Pathology. Tokyo: Proceedings of the Japanese Society of Pathology, 2019:420.
17. Reinke S, Bröckelmann PJ, Iaccarino I, et al. Tumor and
microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. Blood. 2020;136(25):2851-2863.
18. Duhrsen U, Muller S, Hertenstein B, et al. Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): a multicenter, randomized phase III trial. J Clin Oncol. 2018;36(20):2024-2034.
19. Tilly H, Gomes da Silva M, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116-125.
20. Pandey S, Mourcin F, Marchand T, et al. IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma. Blood. 2017;129(18):2507-2518.
21. Barraclough A, Bishton M, Cheah CY, Villa D, Hawkes EA. The diagnostic and therapeutic challenges of grade 3B follicular lymphoma. Br J Haematol. 2021;195(1):15-24.
22. Klapper W. Pathobiology and diagnosis of follicular lymphoma. Semin Diagn Pathol. 2011;28(2):146-160.
23. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1(2):187-192.
24. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99(10):3806-3812.
25. Salaverria I, Philipp C, Oschlies I, et al. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood. 2011;118(1):139-147.
26. Klapper W, Kreuz M, Kohler CW, et al. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B- cell lymphoma. Blood. 2012;119(8):1882-1887.
27. Au-Yeung RKH, Arias Padilla L, Zimmermann M, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4- rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020;190(5):753-763.
Haematologica | 107 September 2022
2153